Changes of endothelin in streptozotocin-induced diabetic rats: Effects of an angiotensin converting enzyme inhibitor, enalapril maleate

Journal of Endocrinology

Volumn 175, Issue 1, 2002, Pages 233-239

  Itoh, Y ^a   Imamura, S ^a   Yamamoto, K ^a   Ono, Y ^a   Nagata, M ^a   Kobayashi, T ^a   Kato, T ^a   Tomita, M ^a   Nakai, A ^a   Itoh, M ^a   Nagasaka, A ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; ENDOTHELIN 1; N ACETYLGLUCOSAMINE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DRUG EFFECT; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL;

ACETYLGLUCOSAMINIDASE; ALBUMINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENALAPRIL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; KIDNEY; MALE; MICROSCOPY, ELECTRON; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 18644365067     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1750233     Document Type: Article

References (42)

1. Anderson S, Rennke HG & Brenner BM 1986 Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation 77 1993-2000.
2. Ando K, Hirata Y, Shichiri M, Emori T & Marumo F 1989 Presence of immunoreactive endothelin in human plasma. FEBS Letters 245 164-166.
3. Bradford M 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 248-254.
4. Brenner BM, Meyer TW & Hostetter TH 1982 Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. New England Journal of Medicine 307 652-659.
5. Cohen ML & Kurz KD 1982 Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with Captopril or MK-421. Journal of Pharmacology and Experimental Therapeutics 220 63-69.
6. Cohen ML, Kurz KD & Schenck KW 1983 Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422. Journal of Pharmacology and Experimental Therapeutics 226 192-196.
7. Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K & Chou ST 1994 Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes 43 1221-1228.
8. Dhein S, Hochreuther S, Aus Dem Spring C, Bollig K, Hufnagel C & Raschack M 2000 Long-term effects of the endothelin (A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model. Journal of Pharmacology and Experimental Therapeutics 293 351-359.
9. Emori T, Hirata Y, Ohra K, Shichiri M & Marumo F 1989 Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochemical and Biophysical Research Communications 160 93-100.
10. Fielding BA, Price DA & Houlton CA 1983 Enzyme immunoassay for urinary albumin. Clinical Chemistry 29 355-357.
11. Fujiwara Y, Kitamura E, Ochi S, Shin S, Fukunaga M, Yokoyama K, Fukuhara Y, Ueda N, Kamada T & Orita Y 1991 Isotopic measurement of glomerular intracapillary volume as a quantitative index for mesangial cell contractility. Contributions to Nephrology 95 12-21.
12. Fukui M, Nakamura T, Ebigara I, Makita Y, Osada S, Tomino Y & Koide H 1994 Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. Journal of Laboratory and Clinical Medicine 123 763-768.
13. Gansevoort RT, DeZeeum D & DeJong PE 1993 Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney International 44 579-584.
14. Goetz KL, Wang BC, Madwed JB, Zhu JL & Leadley Jr RJ 1988 Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. American Journal of Physiology 255 R1064-R1068.
15. Heeg JE, DeJong PE, Van Der Hem GK & DeZeeuw D 1987 Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney International 32 78-83.
16. Hocher B, Lun A, Priem F, Neumayer HH & Raschack M 1998 Renal endothelin system in diabetes: comparison of angiotensin-converting enzyme inhibition and endothelin-A antagonism. Journal of Cardiovascular Pharmacology 31 (Suppl 1) S492-S495.
17. Hostetter TH, Troy JL & Brenner BM 1981 Glomerular hemodynamics in experimental diabetes mellitus. Kidney International 19 410-415.
18. Ichikawa I & Harris RC 1991 Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney International 40 583-596.
19. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K & Masaki T 1989 The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. PNAS 86 2863-2867.
20. Itoh Y, Yanagisawa M, Ohkubo S, Kimura C, Kosaka T, Inoue A, Ishida N, Mitsui Y, Onda H, Fujino M & Masaki T 1988 Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Letters 231 440-444.
21. Kawamura M, Ohgawara H, Naruse M, Iwasaki N, Naruse K, Hori S & Omori Y 1993 Plasma endothelin levels in diabetic patients with retinopathy. Journal of the Japanese Diabetes Society 36 125-129.
22. Kohan DE 1991 Endothelin synthesis by rabbit renal tubule cells. American Journal of Physiology 261 F221-F226.
23. Kon V, Fogo A & Ichikawa I 1993 Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney International 44 545-550.
24. Kosaka T, Suzuki N, Matsumoto H, Itoh Y, Yasuhara T, Onda H & Fujino M 1989 Synthesis of the vasoconstrictor peptide endothelin in kidney cells. FEBS Letters 249 42-46.
25. Labarca C & Paigen K 1980 A simple, rapid, and sensitive DNA assay procedure. Analytical Biochemistry 102 344-352.
26. MacCumber MW, Ross CA, Glaser BM & Snyder SH 1989 Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. PNAS 86 7285-7289.
27. Miller WL, Redifield MM & Burnett Jr JC 1989 Integrated cardiac, renal, and endocrine actions of endothelin. Journal of Clinical Investigation 83 317-320.
28. Moreau P, d'Uscio LV, Shaw S, Takase H, Barton M & Luscher TF 1997 Angiotensin II increases tissue endothelin and induces vascular hypertrophy; reversal by ET(A)-receptor antagonist. Circulation 96 1593-1597.
29. Naruse M, Kawana M, Hifumi S, Naruse K, Yoshihara I, Oka T, Kato Y, Monzen C, Kurimoto F, Ohsumi K, Hosoda S & Demura H 1991 Plasma immunoreactive endothelin, but not thrombomodulin, is increased in patients with essential hypertension and ischemic heart disease. Journal of Cardiovascular Pharmacology 17 (Suppl 7) S471-S474.
30. Noto A, Ogawa Y, Mori S, Yoshioka M, Kitakaze T, Hori T, Nakamura M & Miyake T 1983 Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate. Clinical Chemistry 10 1713-1716.
31. Olbrich A, Rosen P, Hilgers RD & Dhein S 1996 Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats. Journal of Cardiovascular Pharmacology 27 187-194.
32. Perrone RD, Madias NE & Levey AS 1992 Serum creatinine as an index of renal function: new insights into old concepts. Clinical Chemistry 38 1933-1953.
33. Ray PE, Aguilera G, Kopp JB, Horikoshi S & Klotmen PE 1991 Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney International 40 764-771.
34. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M & Remuzzi G 1991 Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney International 39 1267-1273.
35. Saito Y, Nakao K, Mukoyama M & Imura H 1990 Increased plasma endothelin levels in patients with essential hypertension. New England Journal of Medicine 322 205.
36. Simonson MS & Dunn MJ 1990 Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates β-adrenergic-mediated cyclic adenosine monophosphate accumulation. Journal of Clinical Investigation 85 790-797.
37. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. Journal of Clinical Investigation 83 708-712.
38. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ & Bloom SK 1990 Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33 306-310.
39. Ulm EH, Hichens M, Gomez HJ, Till AE, Hand E, Vassil TC, Biollaz J, Brunner HR & Schelling JL 1982 Enalapril maleate and a lysine analogue (MK-521): disposition in man. British Journal of Clinical Pharmacology 14 357-362.
40. Unger T & Gohlke P 1990 Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors. American Journal of Cardiology 65 31-101.
41. Wiegmann TB, Herron KG, Chonko AM, MacDougall ML & Moore WV 1992 Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type 1 diabetic patients. Diabetes 41 62-67.
42. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K & Masaki T 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 411-415.